DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways: Erratum

We recently found that there is an inadvertent mistake in our article entitled “DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways”, due to our carelessness. In the article, the representative image of 'p-JNK' for the 'LV-NC' group in Figure 6G was inadvertently misplaced during the image editing process. We would like to correct this with the appropriate image in Figure 6G below. The correction does not affect the original results and conclusions. We are sorry for this mistake and apologize for any inconvenience caused.

Figure 6.

DGCR5 knockdown significantly suppressed tumor growth in vivo. G. IHC staining assay was conducted to detect the expression of the key markers in tumor tissue, the relative expression is showed in the bar charts. * P < 0.05, ** P < 0.01, *** P < 0.001.